AzTrials
AzTrials

Trial phase

Early Phase 1 Clinical Trials

Exploratory first-in-human studies with very small doses and a handful of people, before a standard Phase 1.

6,518 registered studies

In numbers

Open to volunteers
1,541
Active
1,836
All registered
6,518

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 1,541
  • TCR-T Cells, Refractory Solid Tumors

    KSH01-TCRT Solid Tumors

    • Recruiting
    • Age: 18 to 70 years
    • Early Phase 1
    • Injection or infusion

    1) Safety and efficacy of TCR-T cells in subjects with refractory/relapsed solid tumors. 2) The activation and proliferation of TCR-T cells in the subject, and the survival time.

    Conditions
    TCR-T Cells, Refractory Solid Tumors, Relapsed Solid Tumors
    Trial name
    KSH01-TCRT (NCT05539833)
    Testing
    KSH01 injection
    Where
    China
    Volunteers
    50 people
    Sponsor
    TCRx Therapeutics Co.Ltd
    Can I take part? KSH01-TCRT
  • Solid Tumor

    KSH01-R02-101 Solid Tumors

    • Recruiting
    • Age: 18 to 70 years
    • Early Phase 1
    • Injection or infusion

    1. . safety and tolerance 2. . objective response rate

    Trial name
    NCT05580796
    Testing
    KSH01 injection
    Where
    China
    Volunteers
    50 people
    Sponsor
    TCRx Therapeutics Co.Ltd
    Can I take part? NCT05580796
  • Irritability

    Study Brain Mechanisms of Frustration With Magnetoencephalography in Healthy Volunteers

    • Recruiting
    • Age: 18 to 55 years
    • Early Phase 1

    Background: Irritability can be defined as an unusually strong response to frustration; these responses may include severe temper outbursts and a constant grumpy mood.

    Trial name
    NCT06484088
    Testing
    Frustration task
    Where
    2 sites in United States
    Volunteers
    90 people, healthy volunteers welcome
    Sponsor
    National Institute of Mental Health (NIMH)
    Can I take part? NCT06484088
  • Normal Physiology

    Developing Transcranial Neuromodulation Protocols for Learning and Decision-Making

    • Recruiting
    • Age: 18 to 45 years
    • Early Phase 1
    • Medical device

    Background: People with substance use disorder (SUD) often have changes in brain function that can make it difficult to control drug-seeking behavior.

    Trial name
    NCT06561828
    Testing
    continuous Theta Burst Stimulation (cTBS), intermittent Theta Burst Stimulation (iTBS)
    Where
    United States
    Volunteers
    600 people
    Sponsor
    National Institute on Drug Abuse (NIDA)
    Can I take part? NCT06561828
  • Cigarette Smoking-Related Carcinoma

    Sensory Tests of Cigarettes for Identification of Flavors in Current Daily Smoking Adults

    • Recruiting
    • Age: 21 years and older
    • Early Phase 1

    This clinical trial tests how well current daily smoking adults can identify flavors of cigarettes. Menthol cigarettes account for 31 percent of cigarettes sold in the United States.

    Trial name
    NCT06816459
    Testing
    Cigarette smell test, Cigarette Taste Test, Study questionnaires
    Where
    United States
    Volunteers
    30 people, healthy volunteers welcome
    Sponsor
    Roswell Park Cancer Institute
    Can I take part? NCT06816459
  • Normal Physiology

    Causal Mechanisms of Odor-Guided Behavior in Humans

    • Not yet recruiting
    • Age: 18 to 45 years
    • Early Phase 1
    • Medical device

    Background: Little is known about how different regions of the brain responsible for the human sense of smell guide behaviors. In this study, researchers use a technique called transcranial ultrasound stimulation (TUS) to learn…

    Trial name
    NCT07099092
    Testing
    TUS PirC, TUS Amy
    Where
    United States
    Volunteers
    80 people
    Sponsor
    National Institute on Drug Abuse (NIDA)
    Can I take part? NCT07099092
  • Metastatic Castration-resistant Prostate Cancer

    Chemical-Shift-Encoded MRI for Active Bone Marrow Dosimetry in Radiopharmaceutical Therapy

    • Recruiting
    • Age: 18 years and older
    • Early Phase 1
    • Injection or infusion
    • Medical device

    This study compares two different imaging procedures to each other, one using positron emission tomography (PET) with fluorothymidine F-18 (FLT) (FLT PET for short), and the other using chemical shift-encoded (CSE) magnetic…

    Trial name
    NCT07609225
    Testing
    3'-Deoxy-3'-[18F]-fluorothymidine, Chemical-shift-encoded MRI
    Where
    United States
    Volunteers
    15 people
    Sponsor
    University of Wisconsin, Madison
    Can I take part? NCT07609225
  • Autosomal Dominant Polycystic Kidney

    GBP-213 in Patients With Autosomal Dominant Polycystic Kidney Disease

    • Not yet recruiting
    • Age: 18 to 65 years
    • Early Phase 1
    • Injection or infusion

    This study will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of GBP-213 in patients with autosomal dominant polycystic kidney disease (ADPKD).

    Trial name
    NCT07891364
    Testing
    GBP-213
    Where
    China
    Volunteers
    24 people
    Sponsor
    RenJi Hospital
    Can I take part? NCT07891364
  • Lung Cancer, Mesothelioma

    Implantable Microdevices for in Situ Evaluation of Drug Responses in Lung Cancer

    • Not yet recruiting
    • Age: 18 years and older
    • Early Phase 1

    This research is being done to study the safety and feasibility of implanting and retrieving a microdevice that releases microdoses of 20 specific drugs or drug combinations as a possible tool to evaluate the effectiveness of…

    Conditions
    Lung Cancer, Mesothelioma, Suspected Lung Cancer, Suspected Mesothelioma
    Trial name
    NCT07892300
    Testing
    Implantable Micro- drug delivery Microdevice (IMD)
    Volunteers
    20 people
    Sponsor
    Oliver Jonas
    Can I take part? NCT07892300
  • Cannabis Use, Substance Use Disorder (SUD)

    Research Investigating Drug Effects-2 (RiDE-2)

    • Not yet recruiting
    • Age: 18 to 21 years
    • Early Phase 1
    • Pill or oral medicine

    The purpose of this study is to better understand how people's mood, behavior, and brains respond to different recreational drugs.

    Conditions
    Cannabis Use, Substance Use Disorder (SUD), Healthy
    Trial name
    RiDE-2 (NCT06758596)
    Testing
    THC
    Where
    United States
    Volunteers
    144 people, healthy volunteers welcome
    Sponsor
    University of Illinois at Chicago
    Can I take part? RiDE-2

Completed, with results posted

All –
  • Osteopenia

    Melatonin and Osteogenic Loading on Osteopenia

    • Completed
    • Age: 18 years and older
    • Early Phase 1
    • Pill or oral medicine
    • Medical device
    • Results posted

    This study will be assessing the efficacy of melatonin and/or osteogenic loading on modulating bone health in an osteopenic population.

    Trial name
    MelaOstrong (NCT04233112)
    Testing
    Melatonin 5 mg, Osteogenic loading, Mock for Osteogenic Loading
    Where
    2 sites in United States
    Volunteers
    27 people
    Sponsor
    Duquesne University
    Can I take part? MelaOstrong
  • Interaction Drug Food

    Assessing the Pharmacokinetics and Drug Interaction Liability of Kratom, an Opioid-like Natural Product

    • Completed
    • Age: 18 to 55 years
    • Early Phase 1
    • Pill or oral medicine
    • Results posted

    Kratom is a botanical natural product that has opioid-like effects. Kratom is commonly used to self-treat withdrawal symptoms associated with opioid addiction, as well as pain.

    Trial name
    NCT04392011
    Testing
    Midazolam HCl, Dextromethorphan HBr, Kratom
    Where
    United States
    Volunteers
    15 people, healthy volunteers welcome
    Sponsor
    Washington State University
    Can I take part? NCT04392011
  • Endometriosis

    Cardiovascular Disease Risk in Women With Endometriosis

    • Completed
    • Age: 18 to 45 years
    • Early Phase 1
    • Pill or oral medicine
    • Results posted

    To test the hypothesis that estrogen suppression impairs endothelial dysfunction in endometriosis.

    Trial name
    NCT03746535
    Testing
    Elagolix
    Where
    United States
    Volunteers
    21 people, healthy volunteers welcome
    Sponsor
    Yale University
    Can I take part? NCT03746535
  • Mesenchymal Stromal Cells, Cornea

    Safety of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease

    • Completed
    • Age: 18 years and older
    • Early Phase 1
    • Results posted

    This study is a longitudinal assessment using a classic dose-escalation study design to assess the safety and maximal tolerated dose (MTD) of topical MSC Secretome eye drops.

    Conditions
    Mesenchymal Stromal Cells, Cornea, Corneal Defect, Corneal Epithelium Defect
    Trial name
    MSC Secretome (NCT05204329)
    Testing
    MSC Secretome Eye Drops
    Where
    United States
    Volunteers
    9 people
    Sponsor
    University of Illinois at Chicago
  • Carcinoma of the Anal Canal

    Concurrent Chemoradiation + 5-FU + Mitomycin-C in Anal Carcinoma

    • Completed
    • Age: 18 years and older
    • Early Phase 1
    • Injection or infusion
    • Surgery or procedure
    • Results posted

    This research study is a Pilot Study. Pilot studies are conducted to see if it is practical to do this type of research ona larger scale in the future.

    Trial name
    NCT01858025
    Testing
    Pencil Beam scanning Radiation, 5-fluorouracil, Mitomycin-C
    Where
    2 sites in United States
    Volunteers
    25 people
    Sponsor
    Massachusetts General Hospital

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in